Document Detail

Sleep-related breathing in children with mucopolysaccharidosis.
MedLine Citation:
PMID:  19562504     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The mucopolysaccharidoses (MPSs), a group of genetic lysosomal storage disorders, are associated with significant morbidity. Secondarily to specific associated anatomical abnormalities, MPS is associated with sleep disordered breathing (SDB), specifically obstructive sleep apnoea (OSA) that may confer additional morbidity. Few studies have examined SDB in children with MPS using full polysomnography (PSG) and thus the exact prevalence and severity of SDB is unknown. Further, successful treatments for SDB in this population have not been explored. OBJECTIVES: This study evaluated both SDB and the efficacy of treatments offered to children with MPS using PSG data. PATIENTS AND METHODS: A retrospective chart review was conducted on all children with MPS and a history of suspected OSA who were referred to the Hospital for Sick Children, Toronto. Both baseline and follow up treatment PSG data were analysed. PSG data recorded included obstructive apnoea-hypopnoea index (OAHI) and central apnoea index (CAI). RESULTS: Fourteen patients (10 male) underwent a baseline PSG. Three of 14 children on ERT were excluded from the main analyses. The median (range) baseline parameters of the population (n = 11) were recorded. The age was 5.2 years (0.8-17.8) and the body mass index (BMI) was 19.9 (13.7-22.2). The OAHI was 6.6 (0.0-54.8); the CAI was 0.6 (0.0-2.6). Seven of 11 (64%) had evidence for OSA and 3/7 children were classified as having severe OSA (OAHI > 10). Of these, 5/7 children underwent treatment for OSA with 3/5 children showing a significant reduction in their OAHI. Further, the 2 patients on ERT therapy with OSA were also both successfully treated. CONCLUSIONS: Children with MPS have a high prevalence of significant OSA and thus should be carefully screened for OSA using full polysomnography and treated accordingly.
A Nashed; S Al-Saleh; J Gibbons; I MacLusky; J MacFarlane; A Riekstins; J Clarke; I Narang
Related Documents :
22003294 - Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological...
24093894 - Asthma update.
24614764 - Obesity in children with autism spectrum disorder.
23477404 - Statistical persistence and timing characteristics of repetitive circle drawing in chil...
3872714 - Acute traumatic intraventricular hemorrhage in children.
8940984 - Deep breathing in children with severe malaria: indicator of metabolic acidosis and poo...
Publication Detail:
Type:  Journal Article     Date:  2009-06-28
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  32     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-12     Completed Date:  2009-11-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  544-50     Citation Subset:  IM    
The Hospital for Sick Children, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetates / therapeutic use
Anti-Asthmatic Agents / therapeutic use
Child, Preschool
Mucopolysaccharidoses / complications*,  epidemiology,  physiopathology,  therapy
Positive-Pressure Respiration
Quinolines / therapeutic use
Retrospective Studies
Sleep / physiology
Sleep Apnea Syndromes / complications*,  epidemiology,  physiopathology,  therapy
Tonsillectomy / methods
Treatment Outcome
Reg. No./Substance:
0/Acetates; 0/Anti-Asthmatic Agents; 0/Quinolines; 158966-92-8/montelukast

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Orotic aciduria and uridine monophosphate synthase: A reappraisal.
Next Document:  Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with a...